Ginkgo Bioworks Holdings Inc (NYSE: DNA) is 36.05% higher on its value in year-to-date trading and has touched a low of $5.26 and a high of $64.40 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The DNA stock was last observed hovering at around $13.91 in the last trading session, with the day’s loss setting it -0.55%.
Currently trading at $13.36, the stock is 17.53% and 33.28% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.62 million and changing -3.95% at the moment leaves the stock -5.40% off its SMA200. DNA registered -73.70% loss for a year compared to 6-month loss of -12.11%. The firm has a 50-day simple moving average (SMA 50) of $10.0242 and a 200-day simple moving average (SMA200) of $14.12345.
The stock witnessed a 41.53% gain in the last 1 month and extending the period to 3 months gives it a 66.79%, and is 4.21% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.41% over the week and 11.61% over the month.
Ginkgo Bioworks Holdings Inc (DNA) has around 1218 employees, a market worth around $767.92M and $217.95M in sales. Profit margin for the company is -298.78%. Distance from 52-week low is 153.99% and -79.25% from its 52-week high. The company has generated returns on investments over the last 12 months (-52.37%).
with sales reaching $44.43M over the same period.The EPS is expected to grow by 45.22% this year, but quarterly earnings will post -9.45% year-over-year. Quarterly sales are estimated to grow 27.83% in year-over-year returns.
Ginkgo Bioworks Holdings Inc (DNA) Top Institutional Holders
219.0 institutions hold shares in Ginkgo Bioworks Holdings Inc (DNA), with institutional investors hold 73.82% of the company’s shares. The shares outstanding are 41.37M, and float is at 36.49M with Short Float at 21.45%. Institutions hold 68.89% of the Float.
The top institutional shareholder in the company is VIKING GLOBAL INVESTORS LP with over 143.09 million shares valued at $47.83 million. The investor’s holdings represent 7.1383% of the DNA Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 138.96 million shares valued at $46.46 million to account for 6.9327 of the shares outstanding. The other top investors are BAILLIE GIFFORD & CO which holds 134.43 million shares representing 6.7063% and valued at over $44.94 million, while ANCHORAGE CAPITAL GROUP, L.L.C. holds 3.485 of the shares totaling 69.85 million with a market value of $23.35 million.
Ginkgo Bioworks Holdings Inc (DNA) Insider Activity
#####
Still, SEC filings show that on Jan 29 ’25, Che Austin (Officer) Proposed Sale 99 shares at an average price of $12.27 for $1215.0. The insider now directly holds shares of Ginkgo Bioworks Holdings Inc (DNA).
